Post-pandemic Era-Global Pet Vaccine Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
Table of Contents
Global Pet Vaccine Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
- 1.1 Product Details and Introduction
- 1.1.1 Attenuated Live Vaccines -Product Introduction and Major Manufacturers
- 1.1.2 Conjugate Vaccines -Product Introduction and Major Manufacturers
- 1.1.3 Inactivated Vaccines -Product Introduction and Major Manufacturers
- 1.1.4 Subunit Vaccines -Product Introduction and Major Manufacturers
- 1.1.5 Toxoid Vaccines -Product Introduction and Major Manufacturers
- 1.1.6 DNA Vaccines -Product Introduction and Major Manufacturers
- 1.1.7 Recombinant Vaccines -Product Introduction and Major Manufacturers
- 1.2 Market Snapshot
- 1.2.1 Major Companies Overview
- 1.2.2 Market Concentration
- 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
- 2.1 China Pet Vaccine Status and Prospect (2016-2027)
- 2.1.1 China Pet Vaccine Market Size and Growth Rate (2016-2027)
- 2.1.2 China Pet Vaccine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.2 EU Pet Vaccine Status and Prospect (2016-2027)
- 2.2.1 EU Pet Vaccine Market Size and Growth Rate (2016-2027)
- 2.2.2 EU Pet Vaccine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.3 USA Pet Vaccine Status and Prospect (2016-2027)
- 2.3.1 USA Pet Vaccine Market Size and Growth Rate (2016-2027)
- 2.3.2 USA Pet Vaccine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.4 Japan Pet Vaccine Status and Prospect (2016-2027)
- 2.4.1 Japan Pet Vaccine Market Size and Growth Rate (2016-2027)
- 2.4.2 Japan Pet Vaccine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.5 India Pet Vaccine Status and Prospect (2016-2027)
- 2.5.1 India Pet Vaccine Market Size and Growth Rate (2016-2027)
- 2.5.2 India Pet Vaccine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.6 Southeast Asia Pet Vaccine Status and Prospect (2016-2027)
- 2.6.1 Southeast Asia Pet Vaccine Market Size and Growth Rate (2016-2027)
- 2.6.2 Southeast Asia Pet Vaccine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.7 South America Pet Vaccine Status and Prospect (2016-2027)
- 2.7.1 South America Pet Vaccine Market Size and Growth Rate (2016-2027)
- 2.7.2 South America Pet Vaccine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
- 2.8 Pet Vaccine Status and Prospect (2016-2027)
- 2.8.1 Pet Vaccine Market Size and Growth Rate (2016-2027)
- 2.8.2 Pet Vaccine Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Pet Vaccine Market Assessment by Segment
- 3.1 Global Pet Vaccine Capacity and Growth Rate
- 3.2 Global Pet Vaccine Sales by Type
- 3.3 Global Pet Vaccine Sales Revenue by Type
- 3.4 Global Pet Vaccine Consumption by Application
4 Global Pet Vaccine Market Assessment by Regions
- 4.1 Global Pet Vaccine Production Analysis and Forecast by Regions (2016-2027)
- 4.2 Global Pet Vaccine Sales Analysis and Forecast by Regions (2016-2027)
- 4.3 Global Pet Vaccine Sales Revenue Analysis and Forecast by Regions (2016-2027)
5 Value Chain (Impact of COVID-19)
- 5.1 Pet Vaccine Value Chain Analysis
- 5.1.1 Upstream
- 5.1.2 Downstream
- 5.2 COVID-19 Impact on Pet Vaccine Industry
- 5.2.1 Industrial Policy Issued Under the Epidemic Situation
- 5.3 Cost-Under the Epidemic Situation
- 5.3.1 Cost of Raw Material
- 5.4 Channel Analysis
- 5.4.1 Distribution Channel-Under the Epidemic Situation
- 5.4.2 Distributors
6 Competitive Landscape
- 6.1 Global Pet Vaccine Capacity Market Share of Manufacturers (2019-2020)
- 6.2 Global Pet Vaccine Sales Market Share of Manufacturers (2019-2020)
- 6.3 Global Pet Vaccine Sales Revenue Market Share of Manufacturers (2019-2020)
7 Pet Vaccine Competitive Analysis
- 7.1 Bayer Healthcare
- 7.1.1 Bayer Healthcare Company Profiles
- 7.1.2 Bayer Healthcare Product Introduction
- 7.1.3 Bayer Healthcare Pet Vaccine Production, Revenue (2015-2020)
- 7.1.4 SWOT Analysis
- 7.2 Vetoquinol S.A
- 7.2.1 Vetoquinol S.A Company Profiles
- 7.2.2 Vetoquinol S.A Product Introduction
- 7.2.3 Vetoquinol S.A Pet Vaccine Production, Revenue (2015-2020)
- 7.2.4 SWOT Analysis
- 7.3 Boehringer Ingelheim
- 7.3.1 Boehringer Ingelheim Company Profiles
- 7.3.2 Boehringer Ingelheim Product Introduction
- 7.3.3 Boehringer Ingelheim Pet Vaccine Production, Revenue (2015-2020)
- 7.3.4 SWOT Analysis
- 7.4 Ceva
- 7.4.1 Ceva Company Profiles
- 7.4.2 Ceva Product Introduction
- 7.4.3 Ceva Pet Vaccine Production, Revenue (2015-2020)
- 7.4.4 SWOT Analysis
- 7.5 Eli Lilly
- 7.5.1 Eli Lilly Company Profiles
- 7.5.2 Eli Lilly Product Introduction
- 7.5.3 Eli Lilly Pet Vaccine Production, Revenue (2015-2020)
- 7.5.4 SWOT Analysis
- 7.6 Heska Co.
- 7.6.1 Heska Co. Company Profiles
- 7.6.2 Heska Co. Product Introduction
- 7.6.3 Heska Co. Pet Vaccine Production, Revenue (2015-2020)
- 7.6.4 SWOT Analysis
- 7.7 Merck Animal Health
- 7.7.1 Merck Animal Health Company Profiles
- 7.7.2 Merck Animal Health Product Introduction
- 7.7.3 Merck Animal Health Pet Vaccine Production, Revenue (2015-2020)
- 7.7.4 SWOT Analysis
- 7.8 Merial (Sanofi)
- 7.8.1 Merial (Sanofi) Company Profiles
- 7.8.2 Merial (Sanofi) Product Introduction
- 7.8.3 Merial (Sanofi) Pet Vaccine Production, Revenue (2015-2020)
- 7.8.4 SWOT Analysis
- 7.9 Virbac
- 7.9.1 Virbac Company Profiles
- 7.9.2 Virbac Product Introduction
- 7.9.3 Virbac Pet Vaccine Production, Revenue (2015-2020)
- 7.9.4 SWOT Analysis
- 7.10 Zoetis (Pfizer)
- 7.10.1 Zoetis (Pfizer) Company Profiles
- 7.10.2 Zoetis (Pfizer) Product Introduction
- 7.10.3 Zoetis (Pfizer) Pet Vaccine Production, Revenue (2015-2020)
- 7.10.4 SWOT Analysis
8 Conclusion
Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Pet Vaccine market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Pet Vaccine Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Pet Vaccine Market?
Bayer Healthcare
Vetoquinol S.A
Boehringer Ingelheim
Ceva
Eli Lilly
Heska Co.
Merck Animal Health
Merial (Sanofi)
Virbac
Zoetis (Pfizer)
...
Major Type of Pet Vaccine Covered in XYZResearch report:
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Application Segments Covered in XYZResearch Market
Canine
Avian
Feline
For any other requirements, please feel free to contact us and we will provide you customized report.